Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
266 Leser
Artikel bewerten:
(1)

Bexil Corporation Announces Results of Tender Offer

MILLBROOK, NY / ACCESSWIRE / June 2, 2022 / Bexil Corporation (OTC PINK:BXLC) ("Bexil" or the "Company") today announced the results of its tender offer, which expired at 5:00 p.m. ET on June 1, 2022.

Based on the count by Securities Transfer Corporation, the depositary for the tender offer, Bexil accepted for payment an aggregate of 320 shares at a purchase price of $27.50 per share. The depositary will promptly pay for all the shares accepted for payment in accordance with the terms of the tender offer materials.

The number of shares of shares expected to be purchased by the Company and the aggregate purchase price for the shares are subject to final confirmation by the depositary and the proper delivery of shares tendered, including any shares tendered pursuant to the guaranteed delivery procedure.

Subsequent to the expiration of the tender offer, the Company may, in its sole discretion, engage in additional repurchases of shares of the Company. Such repurchases, should they occur, could be made through additional tender offers, solicited or unsolicited transactions in the open market, or in privately negotiated transactions at such times and prices, and on such other terms, as the Company deems appropriate. Such prices and terms may differ from the price and terms of the tender offer.

This announcement is for informational purposes only. This announcement is not an offer to purchase or a solicitation of an offer to purchase any Company shares.

About Bexil Corporation

The objective of Bexil Corporation, a holding company, is to increase book value per share over time for the benefit of its shareholders. The Company is primarily engaged through a wholly owned subsidiary, Bexil Advisers LLC, in investment management. Bexil Advisers is a registered investment adviser and the investment manager to Dividend and Income Fund, a closed end fund (Stock Symbol:DNIF) (NAV Symbol:XDNIX). To learn more about Bexil, including Rule 15c2-11 information, please visit www.Bexil.com.

Safe Harbor Note

This release contains certain "forward looking statements" made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors, many of which are beyond the control of Bexil, which may cause the Company's actual results to be materially different from those expressed or implied by such statements. Investors should carefully consider the risks, uncertainties and other factors, together with all of the other information included in the Company's Annual Report, at http://www.bexil.com/cautionary-language.html, and similar information. The forward looking statements made herein are only made as of the date of this release, and the Company undertakes no obligation to publicly update such forward looking statements to reflect subsequent events or circumstances.

Contact:

Russell Kamerman
Secretary
1-212-785-0900
rkamerman@bexil.com
www.Bexil.com

SOURCE: Bexil Corporation



View source version on accesswire.com:
https://www.accesswire.com/703764/Bexil-Corporation-Announces-Results-of-Tender-Offer

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2022 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.